tag:blogger.com,1999:blog-8989033901007858593.post5060591891851919345..comments2024-03-21T02:41:42.184+01:00Comments on IPTango: Brazil: to promote and increase patentsVerónica Rodríguez Arguijohttp://www.blogger.com/profile/05763207846940036921noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-8989033901007858593.post-49198356618968785352011-11-06T21:36:37.287+01:002011-11-06T21:36:37.287+01:00Thanks Ken, the INPI web page was not working for ...Thanks Ken, the INPI web page was not working for several days so I tried to cover several news. Now re. Does this one promote? Refer to the fact that the case may have to do with the pipeline system (my strong guess because I have not read the case as yet). The situation is that the system has brought so many cases into court – trying to extend the period and so the question refers to the contradiction: is the system unconstitutional and (in some situations) against public interest, and on the other hand some believe that it is not quite reasonable because owners are not entitled to the regular 20-year patent term. Therefore, the question is open – what side of the coin you are on? While many pharmaceutical companies see this as a discouragement, there is the need to bear in mind that until recently pharmaceutical patents were not allowed in Brazil. When they did, they put into place the pipeline system – I would say it is a quid pro quo.Patricia Covarrubiahttps://www.blogger.com/profile/03582697391205609361noreply@blogger.comtag:blogger.com,1999:blog-8989033901007858593.post-41722545325018868122011-11-04T20:54:27.460+01:002011-11-04T20:54:27.460+01:00That's an interesting set of news, thanks for ...That's an interesting set of news, thanks for sending. I don't understand the bit included in the title of the final section ("[does this one promotes?])" -- what are you trying to say there? Please explain.Kennoreply@blogger.com